Page last updated: 2024-12-07

4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone: structure given in first source; a pyridyloxobutylating agent used for altering DNA [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119598
MeSH IDM0217394

Synonyms (18)

Synonym
127686-49-1
4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone
4-(((acetyloxy)methyl)nitrosoamino)-1-(3-pyridinyl)-1-butanone
4-((acetoxymethy)nitrosamino)-1-(3-pyridyl)-1-butanone
1-butanone, 4-(((acetyloxy)methyl)nitrosoamino)-1-(3-pyridinyl)-
4-(acetoxymethylnitrosoamino)-1-(3-pyridyl)-1-butanone
FT-0661104
[nitroso-(4-oxo-4-pyridin-3-ylbutyl)amino]methyl acetate
acetoxymethyl-nnk
4-(acetoxymethyl)nitrosamino]-1-(3-pyridyl)-1-butanone
4-[(acetoxymethyl)nitrosamino]-1-(3-pyridyl)-1-butanone
AB07630
DTXSID20155627
J-005526
AKOS030255490
(nitroso(4-oxo-4-(pyridin-3-yl)butyl)amino)methyl acetate
{nitroso[4-oxo-4-(pyridin-3-yl)butyl]amino}methyl acetate
1-butanone, 4-[[(acetyloxy)methyl]nitrosoamino]-1-(3-pyridinyl)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (40.00)18.2507
2000's10 (50.00)29.6817
2010's2 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]